CoMind Early Feasibility Study
Part of paid clinical trials in Sacramento, California.
- Sponsor
- CoMind Technologies Limited
- Study ID
- NCT06368648
- Status
- Recruiting
Conditions
- Autoregulation
- Encephalitis
- Encephalopathy
- Hydrocephalus
- Intracerebral Hemorrhage
- Intracranial Pressure
- Intracranial Pressure Changes
- Stroke
- Traumatic Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pressure or ICP). Monitoring and managing ICP is an important part of care for patients with conditions such as Traumatic Brain Injury (TBI). However, the current way of measuring ICP requires surgery to drill a hole into the skull, and therefore can introduce additional risks such as infections and pain. Recent research has shown it may be possible to measure ICP without needing surgery. This technology is in development, but large amounts of data is required to build these new devices. Through collecting a large database of information from patients who have both the routine surgical device and the research device applied to their head, the research team will work to develop and test an effective and potentially safer way of monitoring patient ICP.
Key Dates
- Start date
- Nov 27, 2024
- Status verified
- Oct 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 581 participants (estimated)
Arms
- Arm: Patients receiving invasive ICP and ABP monitoring as their standard of carePatients who are receiving invasive Intracranial Pressure (ICP) monitoring and invasive Arterial Blood Pressure (ABP) monitoring as per standard practice will serve as their own controls.
Primary Outcome Measure
A test of the difference in estimation errors between two non-invasive ICP estimation models: one trained with ABP and CoMind One EFS CBFi, and one trained only using ABP [ Time Frame: From enrollment to the end of observation (either 3 weeks after removal of the CoMind device or until ICU discharge, whichever event is sooner) ]
Central Contacts
- David Diedo305-290-1680
- Blake Butler8554493806
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | Jeffrey Vitt, MD (PRINCIPAL_INVESTIGATOR) |
| Christiana Care | Wilmington | Delaware | 19899 | - |
| Medstar Health | Washington D.C. | District of Columbia | 20010 | Jason Chang, MD (PRINCIPAL_INVESTIGATOR) |
| Jackson Memorial Hospital | Miami | Florida | 33136 | Jonathan Jagid, MD (PRINCIPAL_INVESTIGATOR) |
| The University of Kansas Medical Center | Kansas City | Kansas | 66103 | - |
| Washington University Medical Center | St Louis | Missouri | 63110 | Omokhaye Higo, MD (PRINCIPAL_INVESTIGATOR) |
| Albany Medical College | Albany | New York | 12208 | - |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | Sofia Geralemou, MD (PRINCIPAL_INVESTIGATOR) |
| WakeMed | Raleigh | North Carolina | 27610 | |
| Ohio State University | Columbus | Ohio | 43210 | Andrew Springer, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | Danielle Sandsmark, MD, PHD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Christopher Hughes, MD (PRINCIPAL_INVESTIGATOR) |
| Inova Fairfax Medical Campus | Falls Church | Virginia | 22042 | - |
| University of Washington, Harborview | Seattle | Washington | 98104 | Abhijit Lele, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sacramento, CA
Related Studies
- Evaluation of an Advanced Lower Extremity NeuroprosthesesRecruiting · Case Western Reserve University · Cleveland, Ohio
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- Hyperbaric Oxygen Brain Injury Treatment TrialPHASE2 · Recruiting · Gaylan Rockswold · San Diego, California
- Mobile Health Self-Management and Support System for Chronic and Complex Health ConditionsRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania